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Summary 
Structural diversity of lymphocyte antigen receptors (the immunoglobulin [Ig] of B cells and 
the or//3 or y/~ T cell receptor [TCIk] of T cells) is generated through somatic rearrangements 
of V, D, and J  gene segments. Classically,  these recombination events involve gene segments 
from the same Ig or TCR locus. However, occurrence of"trans" rearrangements between distinct 
loci has also been described, although in no instances was the surface expression of the corresponding 
protein under normal physiological conditions demonstrated. Here we show that hybrid TCR 
genes generated by trans rearrangement between Vy and (D) J3 elements are translated into functional 
antigen receptor chains, paired with TCIL cr chains. Like classical or~f3 T  cells, cells expressing 
these hybrid TCR chains express either CD4 or CD8 coreceptors and are frequently alloreactive. 
These results have several implications in terms of T  cell repertoire selection and relationships 
between TCR structure and specificity. First, they suggest that TCR alloreactivity is determined 
by the repertoire selection processes  operating during lymphocyte development rather than by 
structural features specific to Vo~V/5 regions. Second, they suggest the existence of close structural 
relationships between 3,/~i and ol/(3 TCR and more particularly, between Vy and V3 regions. 
Finally, since a significant fraction of PBL (at least 1/104) expressed hybrid TCR chains on their 
surface,  these observations  indicate that  trans rearrangements significantly contribute to  the 
combinatorial diversification of the peripheral immune repertoire. 
"I  mphocyte antigen receptor diversity results from somatic 
DNA recombination between genetic elements origi- 
nally separated on the chromosome, the V, D, and J segments. 
This recombination is mediated by specific enzymes, the lym- 
phoid recombinases, that catalyze the joining of elements 
flanked  by  recombination  signal  sequences  (RSS) 1 com- 
prising highly conserved heptamer and nonamer motifs (1, 2). 
Ig and TCR gene rearrangements are activated in lymphoid 
cells only, at a specific developmental stage and in a sublineage- 
dependent fashion, i.e.,  complete Ig rearrangements occur 
in B ceils only, whereas complete TCtk rearrangements occur 
in T  cells only. Several observations suggest that specificity 
of the recombination process depends on two main parameters: 
first, on the ability of a given cell to activate its recombina- 
tion machinery, as this property is specific to developing lym- 
phocytes, and second, on the ability of a cell to render its 
1 Abbreviations used in this paper: BLCL, B lymphoblastoid  cell line; DP, 
CD4/CD8 double positive; RSS, recombination  signal sequence. 
TCR or Ig loci accessible to recombinases, as this accessi- 
bility is tightly regulated within a given lymphoid sublineage 
(for a review see reference 3). 
Classically,  the IgH and L chains on B cells and the TCR 
c~ and B or y  and 8 chains on T  cells are encoded by genes 
formed by elements belonging to the same locus. However, 
because rearrangements between elements belonging to any 
Ig or TCR locus seem to be mediated by the same recombi- 
nation complex (4, 5), "trans" rearrangements between ele- 
ments belonging to distinct loci could in theory occur provided 
that both loci are accessible to the recombinases at the same 
developmental stage. Hybrid IgH/TCR ot chain genes have 
been described in leukemic cells by several groups about a 
decade ago (6-9). More recently, the occurrence of trans rear- 
rangements between TCR 3" and ~ elements has been demon- 
strated not only in leukemic cells but also in normal PBL 
(10-14).  However, in the absence of any evidence for surface 
expression of the corresponding protein on normal lympho- 
cytes, the physiological significance of these interlocus rear- 
rangements has thus far remained unclear. Here we show that 
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and fl loci are translated  into functional  alloreactive TCR. 
These findings  are discussed  in  terms of lymphoid lineage 
commitment,  repertoire  diversification,  and  TCR  struc- 
tureApecificity  relationships. 
Materials  and Methods 
Reagents and Cells.  The following mAbs were used for flow 
cytometry analyses and immunomagnetic separations: 510 (pan 
[15]), 360 (anti-V"f9 [15]), 23D12 (anti-V3,2, 3, 4 [16]), 4All (anti- 
V"?4 [17]), BMA031 (pan fl [18]), "13CR81 (pan ~ [19]), C'yM1 (pan 
3/[20]), WT31 (anti-CD3~ [21]), and F1 (anti-Va2 [22]). F1 mAb 
was purchased from T-cell Diagnostics (Cambridge, MA). All the 
other mAbs were kind gifts from Drs. F. Romagn6 (Immunotech, 
Marseilles,  France), M. Brenner (Harvard Medical School, Boston, 
MA), W. Tax (National Cancer Institute, Amsterdam, The Nether- 
lands),  A. Moretta  (Instituto per la Ricerca sul Cancro,  Genoa, 
Italy), and G. De Libero (Kantonspital,  Basel,  Switzerland). 
The following B lymphoblastoid cells (BLCL) and mAbs used 
for functional assays were obtained from the VIIth HLA Work- 
shop (New York, 1987): antibodies: D1.12 (anti-DR), Leul0 (anti- 
DQ), PL15 (anti-DP), and W6/32 (anti-HLA class I framework); 
BLCLs: RM (RML), IB (IBW9), BT (BTB), BO (BOLETH), SP 
(SP0010),  and TU (TUBO). 
Generation of 7/3 T Cell Clones and Lines.  PBL from healthy 
donors were sorted, cultured,  and cloned as previously described 
(23 and 24). In brief, cells were incubated with TCR V or C region- 
specific mAb for 45 rain, washed once, and rotated for 4 h at 4~ 
with magnetic beads coated with sheep anti-mouse Ig (Dynal, Oslo, 
Norway). After eight washes, bead-adherent cells were cultured 
in medium (RPMI 1640, 10% human serum, 1 mM t-glutamine, 
rIL-2, leukoagglutinin [0.5/zg/ml]), and irradiated PBL and BLCL. 
Beads were removed at day 5, cells were cultured further,  and at 
day 14, they were subjected to a second immunomagnetic separa- 
tion. After two more weeks of culture, cells were cloned by lim- 
iting dilution in culture medium and irradiated feeder cells. Growing 
colonies with a probability of monoclonality >95 % were kept for 
further analysis. 
Flow Cytometry Analysis and Comodulation Assays.  Cells were 
phenotyped by indirect immunofluorescenee as previously described 
(24).  In brief, cells were incubated first with unconjugated V- or 
C-specific mAb for 30 rain on ice,  washed,  and incubated with 
FITC-conjugated rabbit anti-mouse Ig antiserum for 30 rain on 
ice. For single-color immunofluorescence, cells were resuspended 
in PBS after one washing,  and analyzed by flow cytometry. For 
two-color immunofluorescence, cells were incubated for I0 min 
at room temperature with normal mouse serum, washed, then in- 
cubated for 30 min on ice with biotinylated mAb, washed,  and 
finally, incubated for 30 rain on ice with PE-conjugated streptavidin 
(Immunotech, Marseilles,  France). After washings, cells were ana- 
lyzed by flow cytometry on a FACScan |  apparatus (Becton Dick- 
inson & Co., Mountain View, CA) using the LYSYS II software. 
Comodulation assays were performed as follows: cells were in- 
cubated with irrelevant or biotinylated 23D12 mAb for 30 min on 
ice,  washed  twice,  and  then  incubated  overnight  in  avidinated 
microwell  plates  (Immunotech;  105  cells  per  well).  After  two 
washes, cells were stained and analyzed by flow cytometry as de- 
scribed above. 
Functional Assays.  Proliferation and cytotoxicity assays were per- 
formed as previously described (24, 25). In brief, cytotoxic activity 
of T cell clones was measured by a standard 4-h SlCr-release assay 
at 9:1 and 3:1 E/T cell ratios. Percent specific lysis was calculated 
as described previously (25). Proliferative  activity of responder cells 
was estimated after a 48-h culture with irradiated BLCL followed 
by an overnight pulse with  tritiated  thymidine. 
Amplification and Sequencing of TCR Transcripts.  Preparation of 
T  cell  clone RNA,  reverse  transcription,  amplification,  and se- 
quencing of VyCfl transcripts were performed as previously de- 
scribed (23) using VyI (16) and Cfl (5' GGG AGA TCT CTG CTT 
CTG ATG GCT C) primers. TCR c~ transcripts were analyzed by 
anchored PCR as described earlier (26) using Cc~ (5' GTT AGG 
ATC CTG TTT CAA AGC TTT TCT CGA CCA GC for reverse 
transcription;  5' CTT TGT GAC ACA TTT GTT TGA G for 
second step amplification and sequencing) and polyT (26) primers. 
Results and Discussion 
Characterization of  a PBL Subset Recognized by both Vy- and 
C/~-specific mAb.  In the course of the characterization of a 
mAb termed 23D12, which turned out to be directed against 
a determinant shared by V3"2, V3'3, and V3"4 TCR variable 
regions  (16),  several  23D12 +  polyclonal  cell  lines  were 
generated after immunomagnetic sorting of PBL from healthy 
donors.  Whereas the great majority of 23D12 + lymphocytes 
were recognized by the pan 6 mAb #510 (15) and thus, pre- 
sumably expressed a 3'/6 TCR,  a minor subset recognized 
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Figure  1.  (A) Two-color flow cytometry analysis of sorted 23D12 + T 
cells using pan r, pan ~, and V3,2  , 3, 4-specific  mAb. Shown are the fluores- 
cence contour plots (log scale) of cells from line #83 (Table 1), stained 
by immunofluorescence  using PE-conjugated  BMA031 (pan~) or 510 (Fan~) 
mAb (ordinate, red fluorescence), and purified 23D12 (V'~2,3,4-specific) 
mAb, whose binding was revealed  by FITC-conjugated rabbit anti-mouse 
Ig (abscissa,  green fluorescence). (B) Single-color flow cytometry analysis 
of a 23D12*BMA031 + T cell clone. Va2§  + T cells 
were isolated after sequential immunomagnetic  sorting of PBL using 23D12, 
BMA031, and a Va2.1-specific  mAb (T-cell  Sciences). Shown are the fluores- 
cence histograms (log green fluorescence) using mAb whose specificity 
is shown in the figure. (C) Comodulation of Cfl, Vot2, and V~/4 epitopes 
on a 23D12§  + T cell clone. Cells were incubated overnight with 
(white histograms) or without (black histograms) cross-linked 23D12 mAb, 
washed, and stained by indirect immunofluorescence using CD2, Cfl-, 
Vow2-, and V~4-specific mAbs. Note the partial modulation of the Cfl, 
Vc~2, and Vy4 epitopes, but not of CD2 epitopes, after overnight incuba- 
tion with 23D12 mAb. 
1686  Surface  Hybrid TCR. Chains on Human PBL by the pan B mAb #BMA031 (18) but not by the pan ~ mAb 
was reproducibly detected in most lines analyzed (Fig.  1 A 
and  Table  1).  The proportions  of BMA031 +  cells  among 
23D12 +  T  cells  were  generally  1%,  and  in  about  1/4  of 
the cell  lines  studied,  were  >10%  (Table  1  and  data  not 
shown).  This indicated that cells with this peculiar pheno- 
type were rather frequent under normal physiological condi- 
tions (>/1/104 PBL considering that 23D12 + cells represent 
on average  1%  of PBL  [16]).  To rule out  a possible mAb 
cross-reactivity problem, additional staining experiments were 
performed on 23D12 § BMA031 + T  cell clones using a large 
panel  of TCR  V  and  C  region-specific  mAbs.  Parts  of 
23D12§  cells were recognized by a V'/4-specific 
mAb  (4All  [17])  (Fig.  i  B  and Table 1).  Moreover, all of 
them were stained by the C/3-specific mAb BF1 (20), as well 
as by the WT31 mAb (21), which is directed against a CD3e 
epitope exposed on ct/~ but not on 3'/5 T  cells (data not 
shown).  In  contrast,  23D12+BMA031 +  cells  were recog- 
nized neither by the Cy-specific mAb C3,M1  (20), nor by 
the CtS-specific mAb TCIk~I (19) (data not shown).  Taken 
together, these results confirmed the presence of V3' and C/3 
epitopes and rule out expression of TCR "y and 5 chains on 
23D12+BMA031+  clones. 
All  23DI2+BMA031 + Clones  Express  Productively Rear- 
ranged TCR Genes Comprising V2" and Cfl Elements.  In light 
of recent studies demonstrating the occurrence of TCR chain 
gene rearrangements between TCR 3' and/3  loci (10,  11), 
we suspected the presence of a hybrid TCR chain comprising 
V3' and CB regions on the surface of 23D12+BMA031 + T 
cells. To test this directly, we performed PCR amplifications 
on mRNA  derived from several 23D12 +BMA031 + clones 
using primers  specific to C/3 and to a DNA region shared 
by V3,2, V'y3, and Vy4 elements. A  DNA band of the ex- 
pected size was amplified in all the clones tested using this 
pair of primers. Moreover, sequencing of the amplified cDNA 
demonstrated the occurrence of a productive trans rearrange- 
ment between V)' and J~ elements in all but one case (Fig. 
2).  Some but  not all transcripts  comprised a DB element, 
suggesting that "//~ trans rearrangements could occur both 
before or after partial DJ/3 rearrangements.  An unusual hy- 
brid sequence formed by a recombined Vq/Jy exon spliced 
to a C/3 exon was found in one clone (#71.13, Fig. 2). It has 
been previously proposed that this kind of transcript could 
result from a trans splicing between mRNA from rearranged 
TCR 3, locus and unrearranged TCR/~ locus (11). The fact 
that such a structure was stably expressed in a T  cell clone 
probably rules out a trans splicing event but rather suggests 
the occurrence of a secondary interlocus recombination fol- 
lowing or preceding a normal intralocus VyJ3' rearrangement. 
It is not clear at that stage whether this recombination event 
involves classical heptamer/nonamer RSS flanking the TCR 
V, D, and J elements or yet another signal sequence. In sup- 
Table  1.  Frequency, V'y Usage, and CD4/CD8 Coreceptor Expression by 23DI2+BMA031 + T  Cells Estimated 
by Flow Cytometry 
TCR-/~  TCIk-b  V3,4  CD4  CD8*  V-t4  CD4  CD8* 
PBL line  among 23D12 +  among 23D12+et//~ +  among 23D12+3'/t5 + 
67  1.3  98.8  99.8  0.6  99.9  20.2  0.6  0.0 
69  6.0  94.1  87.1  98.3  4.5  20.0  0.0  1.6 
70  3.0  97.3  57.0  19.4  80.3  47.3  2.8  .0 
71  1.9  98.2  47.4  18.8  53.2  29.1  0.5  1.0 
72  0.0  99.6  ( -  )*  ( -  )  ( -  )  26.5  0.5  1.0 
73  17.0  83.7  0.2  0.7  89.5  1.2  2.0  5.0 
76  1.6  98.3  0.6  17.0  82.0  29.5  0.7  0.0 
83  13.4  85.6  88.4  26.5  37.0  40.0  6.6  0.0 
36  25.4  74.8  98.5  0.8  92.6  95.7  ND  ND 
37  3.6  96.1  97.6  5.1  57.3  89.4  ND  ND 
38  5.0  96.0  99.9  3.9  96.0  34.9  ND  ND 
39  2.0  98.3  97.0  13.2  82.9  74.4  ND  ND 
Mean  6.7  93.4  70.3  18.6  70.4  42.6  1.8  1.2 
23D12 § cultured PBL were recognized in a mutually exclusive  fashion by the pan fl (BMA031 [18]) and the pan t5 (510 [15]) mAb. The percentage 
of V')'4+ (4All + [17]) cells was significantly higher among 23D12+a/fl + than among 23D12§  + lymphocytes (Wilcoxon matched pairs test, 
p  =  0.02). Note that unlike 23D12+3,/t5  + cells, most 23D12+a/fl + cells expressed either CD4 or CD8 coreceptors. 
" Percentage of CD8 bright. 
r No 23D12 +  BMA031 + line could be derived from this individual. The percentage of Vy4 +, CD4 + and CD8 + cells among 23D12  +  a/fl + was 
estimated on sorted 23D12§  § PBL. The percentage of V3'4  +, CD4§  and CD8 + cells among 23D12+y/~ + lymphocytes was deduced 
from a combined analysis of 23D12+ and 23D12§  T cells. 
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C36.Z  V~4D~213p2  1  O~"I~D  TGTSGRASSH  NEQFF  W13 13e42  CA  VE6Y  GGSQGNLIF 
C36.6  Vy4  Jp2 2  CAIYJD  A  NTGELFF  V~2.4 3~30  CAM  SGX  RDKIIF 
C36.17  Vy4  ]p23  CATW  RI  ll)TQYF  va13.13,,22  CA  VAVS  SSGSAKRQLTF 
C37.38  V~4  3pl 2  G~1WDG  LAT  GYTF  V~31  3~29  CAT  XI  GNTPLVF 
C37.40  Vy4  3pl 6  CAlW  EGI  NSPLHF  Va27.13~44  CA  VVGVL  TASKLTF 
C37.47  Vy4  WX  J~45  CAA  SYDGN  SGGGAGDLTF 
C36.1  Vr4  ]pl 3  CAT  PTDR  NTIYF 
Coo  V~4Dp1.13p2.1  CAT  PGGVY  NEQFF 
C71.13  Vy4  3y P2  CATWDG  GGG  DRI  KTF  V028.1J~34  CA  VKG  NTDKLIF 
C76.1  Vy3D~l.lJpl.6  CAT  SWGPIL  SPLHF  Va42  3a36  s  VRVLA  C~NNLF 
C76.3  Vy30ts2.13~2  5  CATWI)  LGTLTE  ETQYF  VJ2  .]alO  CA  VRINV  TGGGNKLTF 
C76.16  Vy3  3p23  CAlW  G  TDTQYF  V~30  Ja52  CA  VQAK  GGTSYGKLTF 
C~1~. 1  Vy3  3p23  CAI~D  TDTQYF  Vc~3 13o54  CA  VT  IQGAQKLVF 
Figure  2.  Deduced amino acid sequences of TClk 
transcripts  expressed  in  23D12+BMA031 +  T  cell 
clones. Clones were derived from six individuals (#36, 
37,  co, 71,  76,  and  70). All clones were stained by 
23D12 and BMA031 mAbs (V'y2,3,4-,  and TCR-/~- 
specific, respectively). All clones except C76.1, C76.3, 
C76.16, and C70.1 were also recognized by the Vq'4- 
specific mAb 4All. V(D)J assignments were deduced 
from a comparative analysis of cDNA sequences de- 
rived  from  23D12*BMA031 +  T  cell  clones  with 
those of known VDJ elements. The following TCR 
nomenclatures  are used throughout  the manuscript: 
Vc~ (from the Xlth International  HLA Workshop, 
1993, Japan), Jc~ (37), J/~ (38), V3' (39), and J'), (39). 
The Va gene expressed by clone C37.47 (termed Vc~k') 
is closely related  to AF211 (40). Clone C71.13 ex- 
pressed a TCR •  chain gene comprising  V3'4J'yP2 exon, normally spliced to a C~2 exon (data not shown).  (NDN) Nongermline and DE-encoded 
amino acids. In the case of TCR ol, most available Vce gene sequences were derived from cDNA clones. Therefore the assignment  of a given junctional 
nucleotide  or amino acid to V~ or to the N  region could not be ascertained.  (-) Not done.  These  sequence data are available from EMBL/Gen- 
Bank/DDBJ under accession numbers  X81536-X81556. 
port of the second possibility,  the three examples of V'yJyCfl 
rearrangements described here and elsewhere (11) involved 
the same Jy segment (Jq,  P2), which would suggest the exis- 
tence of a recombination hot spot located downstream ofJq,  P2, 
and presumably upstream of  J3,2. These results raise the pos- 
sibility that all hybrid TCR 3'/~ rearrangements are preceded 
by a common translocation event. In support of this, a pre- 
Iiminary Southern blot analysis of DNA from several T cell 
clones carrying either V'yJ"/C~, V',/DflJ~Cfl, or V'yJflC/3 
rearrangements demonstrated the existence of a  common 
nonassignable band hybridizing with the J'y probe pH60 (27 
and our unpublished observations). An in-depth molecular 
analysis of several of these clones is currently underway. Taken 
together, these results suggest the existence of a primary recom- 
bination event possibly involving signal sequences distinct 
from the Ig and TCR RSS.  If so, understanding its precise 
mechanism might provide clues on the etiology of diseases 
such as ataxia telangiectasia, where the frequency of trans rear- 
rangements between V3' and C~ is on average 10-50-fold 
higher than in normal individuals (11). 
Hybrid TCR  V'yCfl Chains Are Paired to Classical VceCcr 
Chains.  In several polyclonal lines,  a significant fraction of 
23D12 +BMA031 + T cells was recognized by a Vot2-specific 
mAb (data not shown). Moreover, productive TCR ot chain 
gene transcripts were detected in all the 23D12 +BMA031 § 
clones studied (Fig.  2), suggesting that the hybrid TCR 
chain was paired with a TCR ot chain. To formally prove 
this,  we  isolated  a  Vot2+23D12§  +  T  cell  clone 
after immunomagnetic sorting (Fig. 1 B), confirmed the pres- 
ence of V'y4CB and Vo~2Cot transcripts, and then, demon- 
strated a physical association between the V'y4CB and the 
V2JCot TCR chains by comodulation experiments using C~-, 
V3'-,  and Vot-specific  mAbs (Fig.  1 C). 
Evidence for a Preferential Usage of Particular V7 but not Vcr 
Region Genes  by V'fCfl + Cells.  A previous analysis of hy- 
brid V'yC~ gene rearrangements derived from normal PBL 
suggested a biased Vy gene usage in favor of Vy4 (11). Ac- 
cordingly, the proportions of cells recognized by the V'y4- 
specific  mAb 4All  (17)  were significantly higher  among 
V"/CB +  than  among  Vq/Cy +  cells  (Table  1).  Moreover, 
whereas we could derive cells expressing hybrid V'yC3 chains 
using either V3,2, V3'3, or V3'4 genes from 19/20 PBL samples 
(Table  1 and data not  shown),  we were unable to isolate 
cells expressing V3,9C3 chains despite numerous attempts. 
In contrast to V3,,  the Vot repertoire of 23D12+c~/3 + T 
cells was not biased toward usage of a particular Vc~ region. 
Indeed, analysis of TCR Vot gene expression in polyclonal 
23D12 +  c~/~ + T  celI lines using a panel of primers specific 
to the 29 Vc~ families demonstrated usage of distinct sets of 
Vot genes from one line to another (data not shown). Ac- 
cordingly,  productive  Vot  transcripts  derived  from  the 
23D12 § or/3 + T cell clones studied comprised diverse V re- 
gion genes (Fig.  2). 
The process leading to underrepresentation of Vq,9Cfl + 
and overrepresentation of V3,4Cfi § cells irrespective of their 
Vce region is yet unclear. During development, rearrange- 
ments involving C-proximal V genes, such as V3'9, are acti- 
vated at earlier stages than those involving C-distal V genes, 
such as V3/2, 3, and 4 (28). Perhaps V3'9 rearrangements occur 
at a stage when the whole ~/locus is not yet accessible to 
recombinases and thus,  accessibility  or combinatorial con- 
straints  might  account for the absence of Vy9C3 + cells. 
However, this cannot explain a biased V'y gene usage in favor 
of Vy4 because such a bias was observed among productive 
but  not  among nonproductive hybrid rearrangements in- 
volving V3' elements from the first V3' family (11). It is pos- 
sible that the structure of some Vq/regions is more or less 
compatible with stable  conformation of the hybrid V7C3 
chain and/or proper pairing with TCR c~ chains.  Also, bi- 
ased usage of Vy but not Va region by V3/C~/§ cells might 
result from an in vivo selection by superantigens, whose rec- 
ognition classically imposes constraints on one of the TCR 
V regions only (29).  In this respect, some Vy regions, like 
most VB regions, show affinity for certain staphylococcal su- 
perantigens (30). 
CD4  and  CD8  Coreceptor  Expression  by  V'yCfl + 
Cells.  During their intrathymic development, ot/B and y/6 
T cells follow two distinct differentiation pathways. Whereas 
most 3'/6 thymocytes remain CD4- CDS-  throughout de- 
velopment,  almost  all  c~/~/ T  cells  go  through  a  CD4 § 
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ence 31). Positive selection of these immature DP a/13 thymo- 
cytes by self-peptide-MHC complexes leads then to their ter- 
minal  differentiation  into  CD8+CD4 -  or  CD8-CD4 § 
mature thymocytes (31). Because almost all 23D12 +  or//3 T 
cells expressed either CD4 or CD8 coreceptors, unlike their 
3,/6 counterparts (Table 1), they probably differentiated from 
DP cells. Recent studies (32) have shown that transition to 
the DP stage tightly depends on the occurrence of a produc- 
tive TCR B rearrangement. Therefore, the fact that  CD4 
and CD8 expression was induced after either V/3D/3J~C~ 
or Vq'(DB) J/5C/5 rearrangement within the precursor cell 
would indicate that transition to the DP stage is primarily 
dictated by the locus origin of the constant rather than the 
variable part of the rearranged gene, which is in accordance 
with recent observations made by others (33). 
Alloreactivity  of  V'rCfl + Lymphocytes.  Unlike  y/~5  T 
cells, a large fraction of or//8 T cells is reactive against poly- 
morphic allogeneic MHC  molecules. This allorecognition 
probably reflects the close structural relationships between 
the allogeneic MHC molecules recognized by mature c~//3 
T cells and the self-MHC-peptide complexes against which 
immature or//3 T cells have been positively selected (34). Anal- 
ysis of the reactivity of polyclonal 23D12 +  ol//3 + T cell lines 
toward six randomly chosen allogeneic B cells revealed strong 
proliferative (Fig. 3 A) or cytotoxic (Fig.  3 D) responses of 
most lines against one or more allogeneic cells.  Moreover, 
alloresponses  of some  23D12+c~//3 +  clones  derived from 
these lines (Fig. 3 B) were blocked by the W6/32 mAb, which 
is directed against a constant part of classical MHC class I 
molecules (Fig. 3, C and D). Together with the presence of 
either CD4 or CD8 coreceptors on most 23D12 +  or//3 + T 
cell clones (Table 1), these results strongly suggest that the 
ligands recognized by 23D12 +or//3 + cells are very similar to 
those recognized by "classical"  ot/B T  cells. 
These observations have several implications with respect 
to TCR selection processes  and structural relationships be- 
tween ot/~ and 3'/6 TCR. Since most 3'/6 cells (including 
23D12 + cells) are CD4-CD8-  and are not aUoreactive (35), 
this would indicate that the same V region can participate 
in the recognition of distinct sets of ligands depending on 
the TCR chain to which it is associated.  These results also 
suggest a close structural relationship between V3' and V/3 
regions, an assumption which is also supported by the fact 
that both V regions display superantigenic reactivity (29, 30), 
unlike Vot and V~ regions. A nice parallel might be drawn 
between the relative interchangeability between VB and V3' 
regions, which is  supported by the present data,  and the 
Va/V~  interchangeability, which is  suggested by studies 
demonstrating the occurrence of V~Cc~ rearrangements (36). 
It should be mentioned, however, that given the peculiar or- 
ganization of the ot/~ locus,  V~Coz chains, unlike V3'C~ 
chains, are formed by a classical intralocus rearrangement. 
In light of these observations, one could imagine the very 
same V3,V~ combination to be associated with either CotC~ 
or C3,Cc5 regions. By comparing the antigenic specificity of 
these cells, it should be possible  to directly test whether al- 
loreactivity is a feature acquired through intrathymic TCR 
selection or whether it is dictated by germline motifs on Va 
and/or V~ regions. 
Concluding Remarks.  Here we have shown that a significant 
fraction of peripheral ot/B T  cells expressed surface hybrid 
receptors formed by interlocus recombination between TCR 
Vy and (D) JB elements. Moreover, these cells displayed most 
features of mature or~15 T  cells and expressed functional al- 
loreactive TCR. Hence, these results indicate that TCR trans 
rearrangements represent a novel mode of diversification that 
truly contributes to the combinatorial diversity of the pe- 
ripheral immune repertoire. 
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Figure  3.  Functional analysis of alloresponses mediated by 
23D12 + ot/3 + T  cells. (.4) Proliferative response of polyclonal 
23D12+cff/3 +  T  cell lines after  coculture with  allogeneic 
BLCL.  Polyclonal  23D12+BMA031 +  lines  (>99%  pure) 
were cultured for 48 h in the presence of randomly chosen 
irradiated allogeneic BLCL, and pulsed for 18 h with tritiated 
thymidine ([3H]TdR).  Shown are the proliferative responses 
([3H]TdR uptake expressed in cpm  x  10 -3) of five cell lines 
(#69, 70,  7I,  76,  and 83) against  six BLCL (RM, IB, BT, 
BO,  SP,  and  TU).  (B)  Proliferative alloresponses  of two 
23D12+cff/3 + T  cell clones. Shown are the proliferative re- 
sponses (expressed in cpm  x  10 -3) of two 23D12+BMA031 + 
T cell clones derived from line #76 (clone #76.3:CD8 + [/eft] 
and #76.1:CD4 + [right]; see Fig. 2) against four allogeneic 
BLCL (TU, BO, BT, and RM).  Several  other alloreactive 
clones derived from this and other lines were obtained but 
are not shown here. (C) Blockage of allogeneic BLCL-induced proliferation of a 23D12 § ot/3 + T  cell clone by anti-HLA mAb. The proliferative ac- 
tivity of a 23D12 + BMA031 + T  cell clone derived from line #76 (#76.3:CD8 +, see Fig. 2) was estimated in the absence or presence of mAb directed 
against HLA framework determinants:  W6/32 (anti-HLA I), D1.12 (anti-HLA DR), Leul0 (anti-HLA DQ), and PL15  (anti-HLA DP). Results are 
expressed in cpm  x  10 -3. (D) Blockage of 23D12+~/3 + T  cell-mediated cytolysis of an allogeneic BLCL by anti-HLA mAb. Cytolytic activity of 
23D12 +BMA031 + cells (line #70) against the allogeneic BLCL BO was estimated in the absence (-) or presence of anti-HLA framework mAb (see 
C). Results are expressed as percent specific target lysis (ordinate)  calculated  at 9:1 and 3:1 E/T ratios.  Similar results were obtained with the 23D!2+c~//3 + 
T  cell clone #70.1  derived from this line (Fig. 2 and data  not  shown). 
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